OMNI-EGFR
Live / Applied — Second extension granted (statement of use) (as of 26 Jan 2026)
What this means for you
Not registered yet, but its 16 Jan 2024 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98358756
- Mark type
- Stylized text
- Filed
- 16 Jan 2024
- Published for opposition
- 28 Jan 2025
- Attorney of record
- Julia Spoor Gard
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical products for the treatment of cancer
Owner
- BlossomHill Therapeutics, Inc., San Diego, CA, US
- BlossomHill Therapeutics, Inc., San Diego, CA, US
Prosecution history
- 27 Jan 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 26 Jan 2026 — SOU EXTENSION 2 GRANTED
- 26 Jan 2026 — SOU EXTENSION 2 FILED
- 26 Jan 2026 — SOU TEAS EXTENSION RECEIVED
- 23 Aug 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 22 Aug 2025 — SOU EXTENSION 1 GRANTED
- 22 Aug 2025 — SOU EXTENSION 1 FILED
- 22 Aug 2025 — SOU TEAS EXTENSION RECEIVED
- 25 Mar 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 28 Jan 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 28 Jan 2025 — PUBLISHED FOR OPPOSITION
- 22 Jan 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 06 Jan 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 29 Nov 2024 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 27 Nov 2024 — CORRESPONDENCE RECEIVED IN LAW OFFICE